Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117168 · ClinicalTrials.gov registry record
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
A clinical trial of Leukemia and Sarcoma, sponsored by Children's Oncology Group.
- Active
- Registry status
- 57,816
- Enrollment target
- 1
- Study location
NCT01117168 is a study of Leukemia and Sarcoma that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 57,816 participants, above the 239-participant average among 233 other Leukemia trials with a reported enrollment target (24091% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01117168, a study of Leukemia and Sarcoma, is active but no longer recruiting, sponsored by Children's Oncology Group.
- ACTIVE NOT RECRUITING
- Registry status
- 57,816 participants
- Enrollment target
- 1
- Study location
Study Summary
The Children's Oncology Group has established a research network, the Childhood Cancer Research Network (CCRN), to collect information about children with cancer and other conditions that are benign but involve abnormal cell growth in order to help doctors and scientists better understand childhood cancer. The CCRN's goal is to collect clinical information about every child diagnosed with cancer and similar conditions in the United States and Canada, to allow researchers to study patterns, characteristics, and causes of childhood cancer. The information can also help researchers study the causes of childhood cancer. To expand the CCRN, parents of children who have been diagnosed with cancer will be asked to provide information about themselves and their child for research purposes.
Conditions Studied
Study Locations (1)
California
- Children's Oncology Group - Arcadia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57,816 participants |
| Start Date | 2010-04-30 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117168
The ClinicalTrials.gov registry entry for NCT01117168 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 57,816 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 239-participant average among 233 other Leukemia trials with a reported enrollment target (24091% higher). The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Leukemia appearing as the primary indexed condition, and to 0 interventions.
NCT01117168 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01117168 about?
NCT01117168 is a clinical study titled "Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group". The Children's Oncology Group has established a research network, the Childhood Cancer Research Network (CCRN), to collect information about children with cancer and other conditions that are benign but involve abnormal cell growth in order to help doctors and scientists better understand childhood ...
What is the current status of trial NCT01117168?
This trial is currently active not recruiting. The enrollment target is 57,816 participants. The study started on 2010-04-30. Estimated completion is 2030-12-31.
What conditions does trial NCT01117168 study?
This clinical trial studies the following conditions: Leukemia, Sarcoma, Pediatric Cancer, Brain Tumors.
Who is sponsoring clinical trial NCT01117168?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01117168 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.